Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Samsung Biologics 207940.KS | Biotechnology | $48.7B | -2% | -6% | -20% | 43% | 34.4× |
| Celltrion 068270.KS | Biotechnology | $34.9B | +5% | +12% | +40% | 32% | 33.9× |
| ALTEOGEN 196170.KS | Biotechnology | $8.80B | -26% | -56% | +61% | 53% | 42.0× |
| Samsung Epis 0126Z0.KS | Pharmaceuticals: Major | $6.49B | +10% | -31% | n/a | 12% | 23.8× |
| SKBP 326030.KS | Pharmaceuticals: Major | $5.03B | +15% | -16% | +37% | 38% | 21.5× |
| Yuhan 000100.KS | Pharmaceuticals: Major | $4.11B | -7% | -10% | +8% | 6% | 40.4× |
| HanmiPharm 128940.KS | Pharmaceuticals: Major | $3.95B | +16% | -2% | +14% | 16% | 15.0× |
| HLB 028300.KS | Biotechnology | $2.69B | -37% | -49% | +26% | -96% | n/a |
| Hanmi Science 008930.KS | Medical Distributors | $2.58B | +19% | +48% | +6% | 4% | n/a |
| Sam Chun Dang Pharm 000250.KS | Pharmaceuticals: Major | $2.36B | -33% | -66% | +23% | 7% | n/a |
| SKBS 302440.KS | Biotechnology | $2.25B | +7% | -12% | +11% | -23% | n/a |
| PharmaResearch 214450.KS | Pharmaceuticals: Major | $2.10B | 0% | -24% | +29% | 37% | 15.4× |
| Hanall Biopharma 009420.KS | Pharmaceuticals: Major | $2.01B | +26% | +12% | +5% | 3% | n/a |
| Hugel 145020.KS | Biotechnology | $1.69B | +8% | -30% | +17% | 38% | 18.1× |
| ABL Bio 298380.KS | Pharmaceuticals: Major | $1.51B | -19% | -71% | -53% | -201% | n/a |
| Peptron 087010.KS | Biotechnology | $1.49B | -17% | -68% | -13% | -488% | n/a |
| LigaChem Biosciences 141080.KS | Pharmaceuticals: Major | $1.48B | -23% | -72% | -55% | -324% | n/a |
| Mezzion Pharma 140410.KS | Pharmaceuticals: Major | $1.43B | +10% | -15% | +13% | -211% | n/a |
| Voronoi 310210.KS | Pharmaceuticals: Major | $1.43B | -23% | -62% | -100% | -438,152% | n/a |
| OliX Pharmaceuticals 226950.KS | Pharmaceuticals: Major | $1.35B | -20% | -51% | +27% | -384% | n/a |
| Celltrion Pharm 068760.KS | Pharmaceuticals: Major | $1.33B | +2% | -23% | +16% | 12% | n/a |
| D&D Pharmatech 347850.KS | Pharmaceuticals: Major | $1.22B | -12% | -49% | -77% | -2,324% | n/a |
| GC Biopharma 006280.KS | Pharmaceuticals: Major | $1.12B | -1% | -10% | -3% | 4% | 4.6× |
| ST Pharm 237690.KS | Pharmaceuticals: Major | $1.11B | -24% | -51% | +26% | 18% | 27.8× |
| CLASSYS 214150.KS | Medical Specialties | $1.08B | -25% | -60% | +16% | 43% | 13.7× |
| L&C BIO 290650.KS | Medical Specialties | $943M | -36% | -37% | +65% | 20% | n/a |
| Oscotec 039200.KS | Pharmaceuticals: Major | $923M | -14% | -32% | +510% | 59% | 50.2× |
| SK Discovery 006120.KS | Pharmaceuticals: Major | $866M | -1% | +25% | +24% | 3% | n/a |
| Daewoong Pharm 069620.KS | Pharmaceuticals: Major | $856M | -7% | -33% | +9% | 12% | 9.0× |
| DongKook Pharmaceutical 086450.KS | Pharmaceuticals: Major | $855M | -3% | +9% | +13% | 10% | 14.0× |
| Seegene 096530.KS | Medical Specialties | $808M | -36% | -26% | +13% | 13% | 20.0× |
| HK inno.N 195940.KS | Medical/Nursing Services | $783M | +4% | -28% | +7% | 12% | 12.3× |
| Livsmed 491000.KS | Medical Specialties | $687M | -15% | -47% | +89% | -77% | n/a |
| SD Biosensor 137310.KS | Electronic Equipment/Instruments | $647M | +5% | -15% | +10% | -6% | n/a |
| Chongkundang 185750.KS | Pharmaceuticals: Major | $609M | -9% | -27% | +6% | 4% | 11.4× |
| Boryung 003850.KS | Pharmaceuticals: Major | $554M | +3% | -13% | +6% | 6% | 11.3× |
| Daewoong 003090.KS | Pharmaceuticals: Major | $495M | 0% | -28% | +6% | 11% | 4.1× |
| Myung in Pharm 317450.KS | Pharmaceuticals: Other | $466M | +1% | -20% | +7% | 35% | n/a |
| PROTEINA 468530.KS | Medical Specialties | $460M | +25% | +5% | -59% | -1,178% | n/a |
| JS Link 127120.KS | Medical/Nursing Services | $458M | -17% | -62% | +39% | -83% | n/a |
| Komipharm International 041960.KS | Biotechnology | $454M | -14% | -2% | -6% | -1% | n/a |
| Qurient 115180.KS | Biotechnology | $452M | -35% | -56% | -14% | -512% | n/a |
| Dong-A Socio 000640.KS | Pharmaceuticals: Major | $447M | -4% | -8% | +11% | 7% | 7.3× |
| Hyundai Bioscience 048410.KS | Pharmaceuticals: Major | $424M | -10% | -50% | +78% | -580% | n/a |
| JW Pharmaceutical 001060.KS | Pharmaceuticals: Major | $423M | -7% | -26% | +9% | 13% | 6.3× |
| Rznomics 476830.KS | Biotechnology | $418M | -20% | -76% | -65% | -1,112% | n/a |
| G2GBIO 456160.KS | Biotechnology | $416M | -9% | -53% | -45% | -2,884% | n/a |
| SEERS 458870.KS | Medical Specialties | $392M | -46% | -70% | +174% | 37% | 15.2× |
| InBody 041830.KS | Medical Specialties | $380M | -21% | -13% | +22% | 22% | 11.3× |
| Onconic Therapeutics 476060.KS | Biotechnology | $368M | -22% | -49% | +179% | 21% | n/a |
| Pharmicell 005690.KS | Pharmaceuticals: Major | $364M | -22% | -55% | +46% | 32% | 8.2× |
| Medy-Tox 086900.KS | Biotechnology | $350M | -2% | -36% | +3% | 10% | 18.1× |
| GI Innovation 358570.KS | Biotechnology | $339M | -14% | -47% | +1,527% | -918% | n/a |
| BioNote 377740.KS | Medical Specialties | $337M | -2% | -14% | +12% | 18% | 14.4× |
| GC Corp. 005250.KS | Pharmaceuticals: Major | $321M | -3% | -45% | +2% | 3% | n/a |